Biocon Limited has informed the Exchange regarding a press release dated July 03, 2023, titled "After Five Years of Successful Experience Internationally, Biocon Biologics Hulio�� Biosimilar to Humira��, Now Available in the United States".
Press Release Jul 03 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Biocon
- Press Release Jun 30 2023
- Press Release May 23 2023
- Press Release Apr 05 2023
- Press Release Apr 03 2023
- Press Release Mar 28 2023
Later from Biocon
- Press Release Jul 05 2023
- Biocon Limited Press Release Jul 24 2023
- Press Release Jul 27 2023
- Press Release Aug 04 2023
- Biocon Limited Press Release Aug 10 2023
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon